Hostname: page-component-7479d7b7d-fwgfc Total loading time: 0 Render date: 2024-07-09T17:23:46.191Z Has data issue: false hasContentIssue false

Maternal cocaine consumption: birth outcome and child development

Published online by Cambridge University Press:  10 October 2008

Virginia Delaney-Black*
Affiliation:
Departments of Pediatrics, Obstetrics and Gynecology and College of Nursing, Wayne State University, Detroit, USA.
Chandice Covington
Affiliation:
Departments of Pediatrics, Obstetrics and Gynecology and College of Nursing, Wayne State University, Detroit, USA.
Robert J Sokol
Affiliation:
Departments of Pediatrics, Obstetrics and Gynecology and College of Nursing, Wayne State University, Detroit, USA.
*
Virginia Delaney-Black MD, Children’s Hospital of Michigan, 3901 Beaubien Detroit, MI 48201, USA.

Extract

The childhood effects of antenatal exposure to cocaine are largely unknown. While several authors have evaluated the consequences of antenatal cocaine exposure during the neonatal period and early childhood, there are no large, blinded and systematic studies of the effects beyond early childhood and no data at early school age.

Type
Articles
Copyright
Copyright © Cambridge University Press 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Kennedy, Senator Edward. Cocaine kindergartners: preparing for the first wave. Senate Hearings 102–367 1991; 5–102–16: 12.Google Scholar
2Koren, G, Shear, H, Graham, K, Einarson, T. Bias against the null hypothesis: the reproductive hazards of cocaine. Lancet 1989; 2: 1440–42.CrossRefGoogle ScholarPubMed
3Toufexis, A. Innocent victims. Time Magazine 1991; May 13: 5660.Google Scholar
4Farrar, HC, Kearns, GL. Cocaine: clinical pharmacology and toxicology. J Pediatr 1989; 115: 665–75.CrossRefGoogle ScholarPubMed
5Cone, EJ, Menchen, SL, Paull, PD, Mell, LD, Mitchell, J. Validity testing of commercial urine cocaine metabolite assays: 1. Assay detection times, individual excretion patterns and kinetics after cocaine administration to humans. J Forensic Sci 1989; 34: 1531.CrossRefGoogle ScholarPubMed
6Ambre, J. The urinary excretion of cocaine and metabolites in humans: a kinetic analysis of published data. J Anal Toxicol 1985; 9: 241–45.CrossRefGoogle ScholarPubMed
7Jones, RT. The pharmacology of cocaine. National Institute of Drug Abuse Research Monograph 1984; 34.Google Scholar
8Stewart, DJ, Inaba, T, Lucassen, M, Kalow, W. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterase. Clin Pharmacol Ther 1979; 25: 464–68.CrossRefGoogle Scholar
9Woods, JR, Plessinger, MA. Pregnancy increases cardiovascular toxicity to cocaine. Am J Obstet Gynecol 1990; 162: 529–33.CrossRefGoogle ScholarPubMed
10Roe, DA, Little, BB, Bawdon, RE, Gilstrap, LC. Metabolism of cocaine by human placentas: implications for fetal exposure. Am J Obstet Gynecol 1990; 163: 715–18.CrossRefGoogle ScholarPubMed
11Randall, T. Cocaine alcohol mix in body to form even longer lasting, more lethal drug. JAMA 1992; 267: 1043–44.CrossRefGoogle ScholarPubMed
12Chasnoff, IJ, Landress, HJ, Barrett, ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas Country, Florida. N Engl J Med 1990; 322: 1202–206.CrossRefGoogle ScholarPubMed
13 Detroit News, 1992; September 16.Google Scholar
14Mc Nagny, SE, Parker, RM. High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic. JAMA 1992; 267: 1106–108.CrossRefGoogle Scholar
15Hanzlick, R, Gowitt, GT. Cocaine metabolite detection in homicide victims. JAMA 1991; 265: 760–61.CrossRefGoogle ScholarPubMed
16Little, BB, Snell, LM, Palmore, MK, Gilstrap, LC. Cocaine use in pregnant women in a large public hospital. Am J Perinatol 1988; 5: 206207.CrossRefGoogle Scholar
17Chasnoff, IJ. Drug use and women: establishing a standard of care. Ann NY Acad Sci 1989; 562: 208–10.Google Scholar
18Zuckerman, B, Amaro, H, Cabral, H. The validity of self-report marijuana and cocaine use among pregnant adolescents. J Pediatr 1989; 115: 812–15.Google Scholar
19Zuckerman, B, Frank, DA, Hingson, R, Amoro, H, Levenson, SM, Kayne, H et al. Effect of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989; 320: 762–68.CrossRefGoogle ScholarPubMed
20Frank, DA, Zuckerman, BS, Amoro, H, Aboagye, K, Bauchner, H, Cabral, H et al. Cocaine use during pregnancy: prevalence and correlates. Pediatrics 1988; 82: 888–95.CrossRefGoogle ScholarPubMed
21Chasnoff, IJ, Landress, HJ, Barrett, ME. The prevalence of illicit drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990; 322: 1202–206.CrossRefGoogle ScholarPubMed
22Ostrea, EM, Brady, MJ, Parks, PM, Arsenio, DC, Naluz, A. Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. J Pediatr 1989; 115: 474–77.CrossRefGoogle ScholarPubMed
23Ostrea, EM, Brady, M, Gause, S, Raymundo, AL, Stevens, M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992; 89: 107–13.Google Scholar
24Spence, MR, Williams, R, DiGregorio, GJ, Kirby-McDonnell, A, Polansky, M. The relationship between recent cocaine use and pregnancy outcome. Obstet Gynecol 1991; 78: 326–29.Google ScholarPubMed
25Moore, T, Sorg, J, Miller, L, Key, T, Resnik, R. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am J Obstet Gynecol 1986; 155: 883–88.CrossRefGoogle ScholarPubMed
26Fantal, AG, Macphail, BJ. The teratology of cocaine. Teratology 1982; 26: 1719.CrossRefGoogle Scholar
27Church, MW, Overbeck, GW, Andrzejczak, AL. Prenatal cocaine exposure in the Long Evans rat: I. Dose-dependent effects on gestation, mortality and postnatal maturation. Neurotoxicol Teratol 1989; 12: 327–34.CrossRefGoogle Scholar
28Chasnoff, IJ, Burns, WJ, Schnoll, SH, Burns, KA. Cocaine use in pregnancy. N Engl J Med 1985; 313: 666–69.Google Scholar
29Ryan, L, Ehrlich, S, Finnegan, L. Cocaine abuse in pregnancy: effects on the fetus and newborn. Neurotoxicol Teratol 1987; 9: 295–99.CrossRefGoogle ScholarPubMed
30Burkett, G, Yasin, S, Palon, D. Perinatal implications of cocaine exposure. J Reprod Med 1990; 35: 3542.Google Scholar
31Critchley, HOD, Woods, SM, Barson, AJ, Richardson, I, Lieberman, BA. Fetal death in utero and cocaine abuse. Br J Obstet Gynaecol 1988; 95: 195–96.CrossRefGoogle ScholarPubMed
32Cherukuri, R, Minkoff, H, Feldman, J, Parekh, A, Glass, L. A cohort study of alkaloid cocaine (“crack”) in pregnancy. J Obstet Gynecol 1988; 72: 147–51.Google ScholarPubMed
33Fulroth, R, Phillips, B, Durand, DJ. Perinatal outcome of infants exposed to cocaine and or heroin in utero. Am J Dis Child 1989; 143: 905–10.Google ScholarPubMed
34Acker, D, Sachs, BP, Tracey, KS, Wise, WE. Abruptio placentae associated with cocaine use. Am J Obstet Gynecol 1983; 146: 220–21.CrossRefGoogle ScholarPubMed
35Macgregor, SN, Keith, LG, Chasnoff, IJ, Rosner, MA, Chisum, GM, Shaw, P et al. Cocaine use during pregnancy: adverse perinatal outcome. Am J Obstet Gynecol 1987; 157: 686–90.Google Scholar
36Chasnoff, IJ, Griffith, DR, MacGregor, S, Dirkes, K, Burns, KA. Temporal patterns of cocaine use in pregnancy: prenatal outcome. JAMA 1989; 261: 1741–44.CrossRefGoogle Scholar
37Oro, AS, Dixon, SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987; 111: 571–78.CrossRefGoogle ScholarPubMed
38Gillogley, KM, Evans, AT, Hansen, RL, Samuels, SJ, Barta, KK.The perinatal impact of cocaine, amphetamine and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol 1990; 163: 1535–42.CrossRefGoogle ScholarPubMed
39Mahliak, MP, Gautieri, RF, Mann, DE. Teratogenic potential of cocaine hydrochloride in CF-1 mice. J Pharm Sci 1980; 69: 703706.CrossRefGoogle Scholar
40Bingol, N, Fuchs, M, Diaz, V, Stone, RK, Gromisch, DS. Teratogenicity of cocaine in humans. J Pediatr 1987; 110: 9396.Google Scholar
41Lipshultz, SE, Frassica, JJ, Orav, EJ. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr 1991; 118: 4451.Google Scholar
42Chasnoff, IJ, Chisum, GM, Kaplan, WE. Maternal cocaine use and genitourinary tract malformations. Teratology 1988; 37: 201204.CrossRefGoogle ScholarPubMed
43Downing, GJ, Horner, SR, Kilbride, HW. Characteristics of perinatal cocaine-exposed infants with necrotizing enterocolitis. Am J Dis Child 1991; 145: 2627.Google Scholar
44Chavez, GF, Mulinare, J, Cordero, JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA 1989; 262: 795–98.CrossRefGoogle ScholarPubMed
45Teske, MP, Trese, MT. Retinopathy of prematurity-like funds and persistent hyperplastic primary vitreous associated with maternal cocaine use. Am J Ophthalmol 1987; 103: 719–20.CrossRefGoogle Scholar
46Dominguez, R, Vila-Coro, AA, Slopis, JM, Bohan, TP. Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child 1991; 145: 688.Google ScholarPubMed
47Little, BB, Snell, LM, Palmore, MK, Gilstrap, LC. Cocaine use in pregnant women in a large public hospital. Am J Perinatol 1988; 5: 206207.Google Scholar
48Volpe, JJ. Effect of cocaine use on the fetus. N Engl J Med 1992; 327: 399407.Google Scholar
49Viscarello, RR, Ferguson, DD, Nores, J, Hobbins, JC. Limb-body wall complex associated with cocaine abuse: further evidence of cocaine’s teratogenicity. Obstet Gynecol 1992; 80: 523–26.Google Scholar
50Sarpong, S, Headings, V. Sirenomelia accompanying exposure of the embryo to cocaine. South Med J 1992; 85: 545–47.Google Scholar
51Hoyme, HE, Lyons-Jones, K, Dixon, SD, Jewett, T, Hanson, JW, Robinson, LK et al. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 1990; 85: 743–47.CrossRefGoogle ScholarPubMed
52Hadeed, AJ, Siegel, SR. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics 1989; 84: 205–10.CrossRefGoogle ScholarPubMed
53Choteau, M, Brickner-Namerow, P, Leppert, P. The effect of cocaine abuse on birth weight and gestational age. J Obstet Gynecol 1988; 72: 351–54.Google Scholar
54Handler, A, Kistin, N, Davis, F, Ferre, C. Cocaine use during pregnancy: perinatal outcomes. Am J Epidemiol 1991; 133: 818–25.CrossRefGoogle ScholarPubMed
55Richardson, GA, Day, NL. Maternal and neonatal effects of moderate cocaine use during pregnancy. Neurotoxicol Teratol 1991; 13: 455–60.Google Scholar
56Sokol, RJ, Martier, A, Ager, J, Giampa, J, Shankaran, S, Jacobson, J et al. Evidence of lack of brain-sparing associated with prenatal cocaine exposure. Proc SGI, San Antonio, Texas March 1991.Google Scholar
57Hack, M, Breslau, N, Weissman, B, Aram, D, Klein, N, Borawski, E. Effect of very low birth weight and subnormal head size on cognitive abilities at school age. N Engl J Med 1991; 325: 231–37.CrossRefGoogle ScholarPubMed
58Kitchen, WH, Doyle, LW, Ford, GW, Callanan, C, Rickards, AL, Kelly, E. Very low birth weight and growth to age 8 years. II: head dimensions and intelligence. Am J Dis Child 1992; 146: 4650.CrossRefGoogle ScholarPubMed
59Chasnoff, IJ, Bussey, ME, Savidh, R, Stack, CM. Perinatal cerebral infarction and maternal cocaine use. J Pediatr 1986; 108: 456–59.CrossRefGoogle ScholarPubMed
60Chaney, NE, Franke, J, Wadlington, WB. Cocaine convulsions in a breast-feeding baby. J Pediatr 1988; 112: 134–35.Google Scholar
61Kramer, LD, Locke, GE, Ogunyemi, A, Nelson, L. Neonatal cocaine-related seizures. J Child Neurol 1990; 5: 6064.CrossRefGoogle ScholarPubMed
62Dobercznk, TM, Shanzer, S, Seine, RJ, Kandall, SR. Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J Pediatr 1988; 113: 354–58.CrossRefGoogle Scholar
63Madden, JD, Payne, TF, Miller, S. Maternal cocaine abuse and effect on the newborn. Pediatrics 1986; 77: 209–11.Google Scholar
64Parker, S, Zuckerman, B, Bauchner, H, Frank, D, Vinci, R, Cubral, HJ. Maternal cocaine abuse and effect on the newborn. Jitteriness in full-term neonates: prevalence and correlates. Pediatrics 1990; 85: 1723.Google Scholar
65Eisen, L, Field, TM, Bandstra, ES, Roberts, JP, Morrow, C, Larson, SK et al. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale. Pediatrics 1991; 88: 477–80.Google Scholar
66Coles, CD, Platzman, KA, Smith, I, James, ME, Fazek, A. Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioural status. Neurotoxicol Teratol 1992; 14: 2333.Google Scholar
67Delaney-Black, V, Covington, C, Ostrea, B, Romero, A, Baker, D, Tagle, M et al. Prenatal cocaine-exposure identified by meconium analysis and behavioral outcome of term infants. Submitted for publication.Google Scholar
68Dixon, SD, Bejar, R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 1989; 115: 770–78.CrossRefGoogle ScholarPubMed
69Heier, LA, Carpanzano, CR, Mast, J, Brill, PW, Winchester, P, Deck, MDF. Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS. Am J Neuroradiol 1991; 12: 951–56.Google ScholarPubMed
70van der Bor, M, Walther, FJ, Sims, ME. Increased cerebral blood flow velocity in infants of mothers who abuse cocaine. Pediatrics 1990; 85: 733–36.Google Scholar
71Shih, L, Cone-Wesson, B, Reddix, B. Effects of maternal cocaine abuse on the neonatal auditory system. Int J Pediatr Otorhinolaryngol 1988; 15: 245–51.CrossRefGoogle ScholarPubMed
72Salamy, A, Eldredge, L, Anderson, J, Bull, D. Brain-stem transmission time in infants exposed to cocaine in utero. J Pediatr 1990; 117: 627–30.CrossRefGoogle ScholarPubMed
73Carzoli, RP, Murphy, SP, Hammer-Knisely, J, Houy, J. Evaluation of auditory brain stem response in full-term infant of cocaine-abusing mothers. Am J Dis Child 1991; 145: 1013–16.Google ScholarPubMed
74Church, MW, Overbeck, GW. Sensorineural hearing loss as evidenced by the auditory brainstem response following prenatal cocaine exposure in the Long Evans rat. Teratology 1991; 43: 561–70.CrossRefGoogle ScholarPubMed
75Lester, BM, Corwin, MJ, Sepkoski, C, Seifer, R, Peucker, M, McLaughlin, S et al. Neurobehavioral syndromes in cocaine-exposed newborn infants. Child Dev 1991; 62: 694705.CrossRefGoogle ScholarPubMed
76Corwin, MJ, Lester, BM, Sepkoski, C, McLaughlin, S, Kayne, H, Golub, HL. Effects of in utero cocaine exposure on newborn acoustical cry characteristics. Pediatrics 1992; 89: 1199–203.CrossRefGoogle ScholarPubMed
77Eisen, L, Field, TM, Bandstra, ES, Roberts, JP, Morrow, C, Larson, SK et al. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale. Pediatrics 1991; 88: 477–80.Google Scholar
78Mayes, LC, Granger, RH, Frank, MA, Schottenfeld, R, Bornstein, MH. Neurobehavioral profiles of neonates exposed to cocaine prenatally. Pediatrics 1993; 91: 778–83.CrossRefGoogle ScholarPubMed
79Telsey, AM, Merrit, AT, Dixon, SD. Cocaine exposure in a term neonate - necrotizing enterocolitis as a complication. Clin Pediatr 1990; 27: 547–50.Google Scholar
80Isner, JM, Estes, M, Thompson, PD, Costanzo-Nordin, MR, Subramanian, R, Miller, G et al. Acute cardiac events temporarily related to cocaine abuse. N Engl J Med 1986; 315: 1438–43.CrossRefGoogle Scholar
81Geggel, RL, McInerney, J, Estes, NA. Transient neonatal ventricular tachycardia associated with maternal cocaine use. Am J Cardiol 1989; 63: 383–84.CrossRefGoogle ScholarPubMed
82Horn, P. Persistent hypertension after prenatal cocaine exposure. J Pediatr 1992; 121: 288–91.CrossRefGoogle ScholarPubMed
83Davidson-Ward, SL, Schultz, S, Krishna, V, Bean, X, Wingert, W, Wachsman, L et al. Abnormal sleeping ventilatory pattern in infants of substance-abusing mothers. Am J Dis Child 1986; 140: 1015–20.Google Scholar
84Chasnoff, IJ, Burns, KA, Burns, WJ. Cocaine use in pregnancy: perinatal morbidity and mortality. Neuro-behav Toxicol Teratol 1987; 9: 291–93.CrossRefGoogle ScholarPubMed
85Bauchner, H, Zuckerman, B, McClain, M, Frank, D, Fried, LE, Kayne, H. Risk of sudden infant death syn-drome among infants with in utero exposure to cocaine. J Pediatr 1988; 113: 831–34.CrossRefGoogle Scholar
86Durand, DJ, Espinoza, RM, Nickerson, BH. Associ-ation between prenatal coaine exposure and sudden infant death syndrome. J Pediatr 1990; 117: 909–11.Google Scholar
87Davidson-Ward, SL, Bautista, D, Chan, L, Derry, M, Lisbin, A, Durfee, MJ et al. Sudden infant death syn-drome in infants of substance-abusing mothers. J Pediatr 1990; 117: 876–81.CrossRefGoogle Scholar
88Bauchner, H, Zuckerman, B. Cocaine, sudden infant death syndrome and home monitoring. J Pediatr 1990; 117: 904906.CrossRefGoogle ScholarPubMed
89Kandall, SR, Gaines, AB. Maternal substance use and subsequent sudden infant death syndrome (SIDS) in offspring. Neurotoxicol Teratol 1991; 13: 235–40.CrossRefGoogle ScholarPubMed
90Perrot, LJ, Nawojczyk, S. Nonnatural death masquer-ading as SIDS. Am J Forensic Med Pathol 1988; 9: 105–11.Google Scholar
91Hoffman, HJ, Damus, K, Hillman, L, Konrad, E. Risk factors for SIDS. Results of the National Institute of Child Health and Human Development SIDS Cooper-ative Epidemiological Study. Ann NY Acad Sci 1988; 533: 1330.Google Scholar
92Toubas, PL, Duke, JC, McCaffree, MA, Mattice, CD, Bendell, D, Orr, WC. Effects of maternal smoking and caffeine habits in infantile apnea: a retrospective study. Pediatrics 1986; 78: 159–62.CrossRefGoogle ScholarPubMed
93Chavez, C, Ostrea, E, Stryker, JC, Smialek, Z. Sudden infant death syndrome among infants of drug-dependent mothers. J Pediatr 1979; 95: 407409.Google Scholar
94Levitt, P. NIDA Grant No. ROI DA06871–02, 1992.Google Scholar
95Dow-Edwards, D. NIDA Grant No. DA04118–06, 1992.CrossRefGoogle Scholar
96 National Health/Education Consortium. Health brain development: precursor to learning. Washington DC: National Commission to prevent Infant Mortality and Institute for Educational Leadership. 1991.Google Scholar
97Riley, E. NIDA Grant No. ROI DA04275–06, 1992.Google Scholar
98Robinson, S. NIDA Grant No. ROI DA04746–03, 1992.Google Scholar
99Habel, L, Kayek, K, Lee, J. Trends in reporting of maternal drug abuse and infant mortality among drug-exposed infants in New York City. Women and Health 1990; 16: 4158.Google Scholar
100Graham, K, Dimitrious, D, Pellegrini, E, Koren, G. Preg-nancy outcome following first trimester exposure to cocaine in social users in Toronto, Canada. Vet Hum Toxicol 1989; 31: 143–48.Google Scholar
101Scott, KG, Urbano, JC, Boussy, OA. Long-term psycho-educational outcome of prenatal substance exposure. Semin Perinatol 1991; 15: 317–23.Google Scholar
102Lapke, J, Goleman, TB, Aldag, JC, Morgan, AM. Developmental follow-up of cocaine exposed infants in foster care. Pediatr Res 1992; 31: 95A.Google Scholar
103Rangel-Friedman, D. Effects of learned helpless para-digm on learning in infants exposed in utero to cocaine (AAC 9021439). Dissertations Abstracts 1990.Google Scholar
104Delaney-Black, V, Roumell, N. The effect of intrautrine cocaine exposure on neurologic status and Fagan Infantest at six months. Pediatr Res 1991; 29: 253A.Google Scholar
105Struthers, J, Hansen, R. Visual recognition memory in drug-exposed infants. Dev Behav Ped 1992; 13: 108–11.Google Scholar
106Hurt, H, Brodsky, N, Gianetta, J, Belsky, J. Comparison of play behaviors in cocaine (coc) exposed and control (con) toddlers: a prospective study. Pediatr Res 1992; 31: 11A.Google Scholar
107Davis, E, Fennoy, I, Laraque, D, Kanem, N, Brown, G, Mitchell, J. Autism and developmental abnormalities in children with perinatal cocaine exposure. J Natl Med Assoc 1992; 84: 315–19.Google ScholarPubMed
108Chasnoff, IJ, Griffith, DR, Freier, C, Murray, J. Cocaine/polydrug use in pregnancy. Pediatrics 1992; 89: 284–89.Google Scholar
109van Baar, A. Development of infants of drug dependent mothers. J Child Psychol Psychiatry 1990; 31: 911–20.Google Scholar
110Howard, J, Beckwith, L, Rodning, C, Kropenske, V. The development of young children of substance-abusing parents: insights from seven years of intervention and research. Zero to three 1989; 9: 816.Google Scholar
111Lapadat, J. Pragmatic language skills of students with language and/or learning disabilities: a quantitative synthesis. J learning Disabilities 1991; 24: 147–58.Google Scholar
112Chasnoff, IJ, Griffith, DR, Freier, C, Murray, J. Cocaine/polydrug use in preganancy: two-year follow-up. Pedia-trics 1992; 89: 284–89.CrossRefGoogle Scholar
113Hurt, H. NIDA Grant No. DA04965–03, 1992.Google Scholar
114Gilchrist, L. NIDA Grant No. DA05208–05, 1992.Google Scholar
115Eyler, FD. NIDA Grant No. DA05854–02, 1992.Google Scholar
116Rosen, TS. NIDA Grant No. ROI DA06171–01A2S1, 1992.Google Scholar
117Chiriboga, C. NIDA Grant No. KO8 NSO1528–02, 1992.Google Scholar
118Sameroff, A, Chandler, MJ. Reproductive risk and the continuum of care-taking causality. Review of child development research (V4). Chicago: UC Press, 1975.Google Scholar
119Cohen, SE et al. Perinatal risk and developmental outcome in preterm infants. Semin Perinatol 1982; 6: 334–39.Google Scholar
120Zuckerman, B. Developmental consequences of mater-nal drug use during pregnancy. Ntl Inst Drug Abuse Res Monogr Ser 1985; 59: 96106.Google Scholar